Open Access
Issue
J Oral Med Oral Surg
Volume 26, Number 2, 2020
Article Number 13
Number of page(s) 7
Section Article pédagogique / Educational article
DOI https://doi.org/10.1051/mbcb/2020006
Published online 07 April 2020
  1. Haute Autorité de Santé − Commission de Transparence − Avis du 3 mai 2017–prégabaline. Available at: https://has-sante.fr/upload/docs/evamed/CT-15083_LYRICA_PIS_RI_Avis2_CT9953&15083.pdf [Google Scholar]
  2. Haute Autorité de Santé − Commission de Transparence − Avis du 18 avril 2018–gabapentine. Available at: https://has-sante.fr/jcms/c_2848081/fr/neurontin [Google Scholar]
  3. Gomes T, Juurlink DN, Antoniou T, et al. Gabapentin, opioids, and the risk of opioid-related death: A population-based nest case-control study. PLoS Med 2017;14:e1002396. [Google Scholar]
  4. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010;17:1113-e88. [CrossRef] [PubMed] [Google Scholar]
  5. Moreau N, Boucher Y. Encyclopédie Médico-Chirurgicale Médecine Buccale: Douleurs oro-faciales [Article 28-290-C-10]. [Google Scholar]
  6. Pizzolato R, Villani V, Prosperini L, et al. Efficacy and tolerability of pregabalin as preventive treatment for migraine: a 3-month follow-up study. J Headache Pain 2011;12:521–525. [CrossRef] [PubMed] [Google Scholar]
  7. Kimos P, Biggs C, Mah J, et al. Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial. Pain 2007;127:151–160. [CrossRef] [PubMed] [Google Scholar]
  8. Kremer M, Salvat E, Muller A, et al. Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights. Neuroscience 2016;338:183–206. [CrossRef] [PubMed] [Google Scholar]
  9. Martinez V, Attal N, Bouhassira D, et al. Les douleurs neuropathiques chroniques : diagnostic, évaluation et traitement en médecine ambulatoire. Recommandations de pratique clinique de la SFETD. Douleurs 2010;11:3–21. [CrossRef] [Google Scholar]
  10. Benoliel R, Kahn J, Eliav E. Peripheral painful traumatic trigeminal neuropathies. Oral Dis 2012;18:317–332. [CrossRef] [PubMed] [Google Scholar]
  11. Alonso-Ezpeleta O, Martin PJ, Lopez-Lopez J, et al. Pregabalin in the treatment of inferior alveolar nerve paraesthesias following overfilling of endodontic sealer. J Clin Exp Dent 2014;6:e197–e202. [CrossRef] [PubMed] [Google Scholar]
  12. Ido-Yonemochi H, Yamada Y, Yoshikawa H, Seo K. Locally produced BDNF promotes sclerotic change in alveolar bone after nerve injury. PLoS ONE 2017;12:e 0169201. [Google Scholar]
  13. Wiffen PJ, Derry S, Bell RF, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews 2017;6:CD007938. [Google Scholar]
  14. Derry S, Bell RF, Straube S, et al. Pregabalin for neuropathic pain in adults. Cochrane Database of Systematic Reviews 2019;1:CD007076. [Google Scholar]
  15. Agence Nationale de Sécurité du Médicament et des Produits de santé − Risques d'abus, de mésuage et de pharmacodépendance liés à l'utilisation de la prégabaline (Lyrica et génériques) − Point d'Information 30/06/2016. Available at: https://www.ansm.sante.fr/S-informer/points-d-information-Points-d-information/Risques-d-abus-de-mesusage-et-de-pharmacodependance-lies-a-l-utilisation-de-la-pregabaline-Lyrica-et-generiques-Point-d-Information [Google Scholar]
  16. Peckham AM, Evoy KE, Oschs L, Covvey JR. Gabapentin for off-label use: Evidence-based or cause for concern? Substance Abuse: Research and Treatment 2018;12:1–8. [CrossRef] [Google Scholar]
  17. Dallel R, Villanueva L, Woda A, et al. Neurobiologie de la douleur trigéminale. Médecine/Sciences 2003;19:567–574. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  18. Tal M, Devor M. Ectopic discharge in injured nerves: comparison of trigeminal and somatic afferents. Brain Res. 1992;579:148–151. [CrossRef] [PubMed] [Google Scholar]
  19. Moreau N, Dieb W, Mauborgne A, et al. Hedgehog pathway-mediated vascular alterations following trigeminal nerve injury. J Dent Res. 2017;96:450–457. [CrossRef] [PubMed] [Google Scholar]
  20. Hargreaves KM. Orofacial pain. Pain 2011;152(3):S25–S32. [CrossRef] [PubMed] [Google Scholar]
  21. Finnerup NB, Haroutounian S, Kamerman P, et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain 2016;157:1599–1606. [CrossRef] [PubMed] [Google Scholar]
  22. International Classification of Orofacial Pain version 1 beta. Available at: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=2ahUKEwjVyICI7cvnAhUhyIUKHflYDFgQFjAAegQIARAB&url=https%3A%2F%2Fwww.ihs-headache.org%2Fbinary_data%2F3468_the-international-orofacial-pain-classification-committee-icop-1-beta-for-review.pdf&usg=AOvVaw2raaYKKDsfL6wQA73Pg422 [Google Scholar]
  23. Moreau N. Rethinking the scope of oral medicine/oral surgery practice: 7 unusual must-know conditions for the oral surgeon. J Oral Med Oral Surg. 2019;25:24. [CrossRef] [Google Scholar]
  24. Sulukdjian A, Nguyen D, Chanlon A, et al. Neuropathies post-implantaires : diagnostic et prise en charge. Implant 2019;25:1–8. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.